Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung | 43 | 2013 | 9857 | 0.990 |
Why?
|
Fas Ligand Protein | 4 | 2013 | 216 | 0.960 |
Why?
|
Lipopolysaccharides | 12 | 2012 | 2216 | 0.890 |
Why?
|
Bronchoalveolar Lavage Fluid | 26 | 2013 | 768 | 0.750 |
Why?
|
Pulmonary Alveoli | 4 | 2013 | 675 | 0.740 |
Why?
|
Pneumonia, Bacterial | 6 | 2012 | 316 | 0.700 |
Why?
|
Bronchial Hyperreactivity | 7 | 2011 | 319 | 0.690 |
Why?
|
Lung Injury | 6 | 2012 | 436 | 0.570 |
Why?
|
Acute Lung Injury | 2 | 2022 | 380 | 0.500 |
Why?
|
Escherichia coli Infections | 4 | 2005 | 532 | 0.460 |
Why?
|
Respiration, Artificial | 11 | 2011 | 2569 | 0.440 |
Why?
|
Inflammation | 13 | 2022 | 10636 | 0.390 |
Why?
|
Chemokines | 4 | 2010 | 970 | 0.380 |
Why?
|
Cytokines | 15 | 2013 | 7323 | 0.370 |
Why?
|
Pulmonary Edema | 1 | 2013 | 414 | 0.370 |
Why?
|
Interleukin-8 | 8 | 2012 | 690 | 0.360 |
Why?
|
Mast Cells | 7 | 2002 | 1544 | 0.360 |
Why?
|
Pseudomonas Infections | 5 | 2012 | 613 | 0.350 |
Why?
|
Duffy Blood-Group System | 2 | 2006 | 58 | 0.340 |
Why?
|
Macrophages, Alveolar | 5 | 2007 | 407 | 0.330 |
Why?
|
Neutrophils | 14 | 2012 | 3721 | 0.300 |
Why?
|
Matrix Metalloproteinase 12 | 1 | 2007 | 49 | 0.300 |
Why?
|
Apoptosis | 8 | 2013 | 9726 | 0.290 |
Why?
|
Pseudomonas aeruginosa | 4 | 2012 | 1219 | 0.270 |
Why?
|
Immunoglobulin E | 9 | 1999 | 1463 | 0.270 |
Why?
|
Toll-Like Receptor 4 | 2 | 2008 | 565 | 0.270 |
Why?
|
Pneumonia | 8 | 2012 | 2133 | 0.260 |
Why?
|
Inflammation Mediators | 3 | 2005 | 1888 | 0.250 |
Why?
|
Tumor Necrosis Factor-alpha | 11 | 2012 | 4424 | 0.230 |
Why?
|
Pneumonia, Pneumococcal | 1 | 2005 | 127 | 0.230 |
Why?
|
Mice | 42 | 2013 | 81202 | 0.220 |
Why?
|
Burkholderia Infections | 2 | 2013 | 44 | 0.220 |
Why?
|
Adenoma | 1 | 2013 | 2174 | 0.210 |
Why?
|
Fever | 1 | 2010 | 1616 | 0.210 |
Why?
|
Cystic Fibrosis | 4 | 2013 | 1178 | 0.200 |
Why?
|
Mice, Inbred C57BL | 18 | 2013 | 21833 | 0.200 |
Why?
|
Animals | 57 | 2022 | 168770 | 0.200 |
Why?
|
Antigens, Fungal | 2 | 2000 | 70 | 0.200 |
Why?
|
Allergens | 4 | 2002 | 1320 | 0.190 |
Why?
|
Chemokine CXCL2 | 4 | 2011 | 115 | 0.180 |
Why?
|
Respiratory System | 3 | 2012 | 557 | 0.180 |
Why?
|
Aspergillus fumigatus | 2 | 2000 | 150 | 0.180 |
Why?
|
Fibrosis | 1 | 2007 | 2029 | 0.180 |
Why?
|
Interleukin-1 | 3 | 2001 | 1263 | 0.180 |
Why?
|
Mice, Mutant Strains | 7 | 2005 | 1865 | 0.180 |
Why?
|
Streptococcus pneumoniae | 1 | 2005 | 714 | 0.170 |
Why?
|
Polysaccharides, Bacterial | 2 | 2012 | 578 | 0.170 |
Why?
|
CD40 Ligand | 1 | 2000 | 526 | 0.170 |
Why?
|
Bone Marrow Transplantation | 8 | 2005 | 2765 | 0.160 |
Why?
|
Oxidants, Photochemical | 1 | 1999 | 78 | 0.160 |
Why?
|
Mice, Inbred Strains | 6 | 2005 | 1828 | 0.160 |
Why?
|
Research Report | 1 | 2022 | 355 | 0.160 |
Why?
|
Epithelial Cells | 3 | 2012 | 3690 | 0.160 |
Why?
|
Chemokine CCL2 | 4 | 2006 | 619 | 0.160 |
Why?
|
Anaphylaxis | 4 | 1997 | 746 | 0.160 |
Why?
|
Methacholine Chloride | 5 | 1998 | 233 | 0.160 |
Why?
|
Neutrophil Infiltration | 3 | 2006 | 391 | 0.150 |
Why?
|
Rabbits | 9 | 2008 | 4894 | 0.140 |
Why?
|
Gene Expression Profiling | 4 | 2011 | 9445 | 0.140 |
Why?
|
Respiratory Syncytial Virus Infections | 2 | 2011 | 329 | 0.140 |
Why?
|
Monokines | 2 | 2006 | 79 | 0.140 |
Why?
|
Escherichia coli | 5 | 2008 | 4217 | 0.140 |
Why?
|
Immunity, Innate | 6 | 2013 | 2962 | 0.140 |
Why?
|
Phagocytosis | 5 | 2012 | 1539 | 0.140 |
Why?
|
Streptococcal Infections | 2 | 1992 | 638 | 0.130 |
Why?
|
Ozone | 1 | 1999 | 469 | 0.130 |
Why?
|
Asthma | 6 | 2000 | 6010 | 0.130 |
Why?
|
Chemotactic Factors | 3 | 2003 | 199 | 0.130 |
Why?
|
Endotoxins | 3 | 2008 | 527 | 0.130 |
Why?
|
Serotonin | 3 | 1994 | 1017 | 0.120 |
Why?
|
Caspase 3 | 2 | 2007 | 758 | 0.120 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2011 | 4751 | 0.120 |
Why?
|
Burkholderia | 1 | 2013 | 38 | 0.120 |
Why?
|
Antigens | 1 | 1999 | 1466 | 0.120 |
Why?
|
Membrane Glycoproteins | 1 | 2005 | 3771 | 0.120 |
Why?
|
Bronchoconstriction | 1 | 1994 | 143 | 0.110 |
Why?
|
Mice, Knockout | 10 | 2011 | 14561 | 0.110 |
Why?
|
Isoproterenol | 1 | 2013 | 399 | 0.110 |
Why?
|
Receptors, Serotonin | 1 | 1994 | 201 | 0.110 |
Why?
|
Respiratory Function Tests | 6 | 2010 | 1617 | 0.110 |
Why?
|
Pyocyanine | 1 | 2012 | 18 | 0.110 |
Why?
|
Antibodies, Anti-Idiotypic | 2 | 1997 | 349 | 0.110 |
Why?
|
Legionella pneumophila | 1 | 1992 | 46 | 0.110 |
Why?
|
Human Experimentation | 1 | 2013 | 127 | 0.110 |
Why?
|
Streptococcus agalactiae | 2 | 1992 | 375 | 0.110 |
Why?
|
Syndecan-4 | 1 | 2012 | 44 | 0.110 |
Why?
|
Burkholderia cepacia complex | 1 | 2012 | 25 | 0.100 |
Why?
|
Receptors, Chemokine | 2 | 2008 | 670 | 0.100 |
Why?
|
Receptors, Tumor Necrosis Factor | 3 | 2005 | 595 | 0.100 |
Why?
|
Ventilator-Induced Lung Injury | 1 | 2013 | 122 | 0.100 |
Why?
|
Aging | 2 | 2009 | 8663 | 0.100 |
Why?
|
Adrenergic beta-Agonists | 1 | 2013 | 346 | 0.100 |
Why?
|
Interleukin-6 | 1 | 2001 | 3203 | 0.100 |
Why?
|
Complement C3a | 1 | 2011 | 69 | 0.100 |
Why?
|
Tachykinins | 1 | 2011 | 78 | 0.100 |
Why?
|
Cell Membrane Permeability | 1 | 2013 | 590 | 0.100 |
Why?
|
Cluster Analysis | 2 | 2009 | 2715 | 0.100 |
Why?
|
Sepsis | 2 | 2008 | 2593 | 0.100 |
Why?
|
Bacterial Proteins | 1 | 2004 | 3854 | 0.100 |
Why?
|
Matrix Metalloproteinase 7 | 1 | 2011 | 58 | 0.100 |
Why?
|
Bronchoalveolar Lavage | 1 | 2011 | 120 | 0.090 |
Why?
|
Oxidants | 1 | 2011 | 164 | 0.090 |
Why?
|
Hydrogen Peroxide | 2 | 2011 | 730 | 0.090 |
Why?
|
Disease Models, Animal | 11 | 2012 | 18034 | 0.090 |
Why?
|
Amino Acid Substitution | 2 | 2005 | 1793 | 0.090 |
Why?
|
Dose-Response Relationship, Immunologic | 2 | 2005 | 370 | 0.090 |
Why?
|
Animals, Newborn | 3 | 1995 | 2726 | 0.090 |
Why?
|
Australia | 1 | 2013 | 1167 | 0.090 |
Why?
|
Bleomycin | 2 | 2008 | 512 | 0.090 |
Why?
|
Legionnaires' Disease | 1 | 1989 | 48 | 0.090 |
Why?
|
Cortisone | 1 | 1989 | 89 | 0.090 |
Why?
|
Cell Degranulation | 4 | 1999 | 287 | 0.080 |
Why?
|
Skin | 2 | 2002 | 4371 | 0.080 |
Why?
|
Mononuclear Phagocyte System | 1 | 2008 | 56 | 0.080 |
Why?
|
Maximal Expiratory Flow Rate | 1 | 1988 | 44 | 0.080 |
Why?
|
Leukocyte Count | 5 | 2003 | 1588 | 0.080 |
Why?
|
Protein-Energy Malnutrition | 1 | 1990 | 187 | 0.080 |
Why?
|
Forced Expiratory Flow Rates | 1 | 1988 | 74 | 0.080 |
Why?
|
In Situ Nick-End Labeling | 1 | 2010 | 644 | 0.080 |
Why?
|
Interferon-gamma | 3 | 1998 | 3207 | 0.080 |
Why?
|
Methionine | 1 | 2011 | 590 | 0.080 |
Why?
|
Male | 32 | 2013 | 350118 | 0.080 |
Why?
|
Oleic Acid | 1 | 2008 | 85 | 0.080 |
Why?
|
Total Lung Capacity | 1 | 1988 | 143 | 0.080 |
Why?
|
Tracheoesophageal Fistula | 1 | 1990 | 129 | 0.080 |
Why?
|
Adoptive Transfer | 3 | 2006 | 844 | 0.080 |
Why?
|
Permeability | 1 | 2009 | 738 | 0.080 |
Why?
|
Spleen | 4 | 2008 | 2362 | 0.080 |
Why?
|
Spirometry | 1 | 2010 | 865 | 0.070 |
Why?
|
Lung Volume Measurements | 1 | 1988 | 378 | 0.070 |
Why?
|
Blood Coagulation | 1 | 2013 | 1127 | 0.070 |
Why?
|
Ovalbumin | 5 | 2002 | 719 | 0.070 |
Why?
|
Esophageal Atresia | 1 | 1990 | 201 | 0.070 |
Why?
|
Phagocytes | 1 | 2008 | 297 | 0.070 |
Why?
|
Glycosaminoglycans | 1 | 2010 | 624 | 0.070 |
Why?
|
Macrophages | 4 | 2012 | 5660 | 0.070 |
Why?
|
Europe | 1 | 2013 | 3339 | 0.070 |
Why?
|
Principal Component Analysis | 1 | 2009 | 940 | 0.070 |
Why?
|
Mice, Inbred C3H | 2 | 2005 | 964 | 0.070 |
Why?
|
Receptors, IgE | 2 | 1999 | 389 | 0.070 |
Why?
|
Multigene Family | 1 | 2009 | 1102 | 0.070 |
Why?
|
Hyperoxia | 1 | 2008 | 262 | 0.070 |
Why?
|
Antibodies, Bacterial | 1 | 2012 | 1470 | 0.070 |
Why?
|
Iontophoresis | 1 | 2005 | 74 | 0.070 |
Why?
|
GATA1 Transcription Factor | 1 | 2006 | 293 | 0.070 |
Why?
|
Sweat | 1 | 2005 | 49 | 0.070 |
Why?
|
Receptors, Tumor Necrosis Factor, Member 6b | 1 | 2005 | 2 | 0.070 |
Why?
|
Species Specificity | 2 | 2008 | 2478 | 0.070 |
Why?
|
Interleukin-17 | 1 | 2011 | 901 | 0.060 |
Why?
|
Flow Cytometry | 3 | 2011 | 5974 | 0.060 |
Why?
|
Tumor Cells, Cultured | 1 | 2013 | 6314 | 0.060 |
Why?
|
Transcription, Genetic | 3 | 2009 | 7722 | 0.060 |
Why?
|
Analysis of Variance | 4 | 2005 | 6366 | 0.060 |
Why?
|
Colony Count, Microbial | 1 | 2005 | 331 | 0.060 |
Why?
|
Cell Movement | 3 | 2010 | 5218 | 0.060 |
Why?
|
Rats, Inbred Strains | 3 | 1992 | 2186 | 0.060 |
Why?
|
Liver Failure | 1 | 2006 | 241 | 0.060 |
Why?
|
Protein Structure, Tertiary | 1 | 2011 | 3848 | 0.060 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2004 | 137 | 0.060 |
Why?
|
Endothelium, Vascular | 2 | 2008 | 4458 | 0.060 |
Why?
|
Endotoxemia | 1 | 2005 | 207 | 0.060 |
Why?
|
Antibodies, Monoclonal | 6 | 2008 | 9274 | 0.060 |
Why?
|
Superoxide Dismutase | 1 | 2005 | 596 | 0.050 |
Why?
|
Chlorides | 1 | 2005 | 667 | 0.050 |
Why?
|
Pulmonary Medicine | 1 | 2004 | 213 | 0.050 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 2 | 2001 | 357 | 0.050 |
Why?
|
Administration, Inhalation | 1 | 2005 | 1105 | 0.050 |
Why?
|
Respiratory Tract Infections | 1 | 2010 | 961 | 0.050 |
Why?
|
Injections, Intradermal | 1 | 2002 | 117 | 0.050 |
Why?
|
Injections, Intravenous | 2 | 2002 | 1420 | 0.050 |
Why?
|
Caspases | 1 | 2005 | 928 | 0.050 |
Why?
|
Immunization | 4 | 1999 | 1256 | 0.050 |
Why?
|
Pulmonary Gas Exchange | 2 | 2002 | 382 | 0.050 |
Why?
|
Iodine Radioisotopes | 2 | 2003 | 1032 | 0.050 |
Why?
|
Specific Pathogen-Free Organisms | 2 | 2008 | 226 | 0.050 |
Why?
|
Respiration | 1 | 1988 | 1653 | 0.050 |
Why?
|
Tidal Volume | 1 | 2003 | 490 | 0.050 |
Why?
|
Chemokines, CXC | 1 | 2003 | 422 | 0.050 |
Why?
|
Blood Bactericidal Activity | 2 | 2012 | 126 | 0.050 |
Why?
|
NF-kappa B | 1 | 2010 | 2499 | 0.050 |
Why?
|
DNA Damage | 1 | 2011 | 2432 | 0.050 |
Why?
|
Gene Regulatory Networks | 1 | 2009 | 1708 | 0.050 |
Why?
|
Neonatal Screening | 1 | 2005 | 591 | 0.050 |
Why?
|
Humans | 26 | 2013 | 744376 | 0.050 |
Why?
|
Receptors, Interleukin-1 | 1 | 2001 | 262 | 0.050 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2001 | 264 | 0.050 |
Why?
|
Myeloid Cells | 1 | 2005 | 810 | 0.050 |
Why?
|
Rats | 6 | 1995 | 24252 | 0.050 |
Why?
|
Immunophenotyping | 1 | 2005 | 1880 | 0.050 |
Why?
|
Vinblastine | 1 | 2002 | 502 | 0.050 |
Why?
|
Receptors, Interleukin-6 | 1 | 2001 | 225 | 0.050 |
Why?
|
Renal Insufficiency | 1 | 2006 | 804 | 0.050 |
Why?
|
Immunoglobulin G | 3 | 2007 | 4561 | 0.040 |
Why?
|
RNA, Messenger | 5 | 2012 | 13035 | 0.040 |
Why?
|
Heart | 2 | 1993 | 4464 | 0.040 |
Why?
|
Nitric Oxide | 1 | 2008 | 2132 | 0.040 |
Why?
|
Intubation, Intratracheal | 3 | 2003 | 1364 | 0.040 |
Why?
|
Oxygen | 1 | 2011 | 4189 | 0.040 |
Why?
|
Minor Histocompatibility Antigens | 2 | 1998 | 298 | 0.040 |
Why?
|
Aerosols | 3 | 1998 | 625 | 0.040 |
Why?
|
Bacteria | 1 | 2010 | 2115 | 0.040 |
Why?
|
Clinical Protocols | 1 | 2004 | 1462 | 0.040 |
Why?
|
Mutation | 5 | 2013 | 29786 | 0.040 |
Why?
|
Respiratory Insufficiency | 2 | 2004 | 1199 | 0.040 |
Why?
|
Collagen | 1 | 2007 | 2688 | 0.040 |
Why?
|
Biological Assay | 1 | 2001 | 652 | 0.040 |
Why?
|
Genetic Variation | 1 | 2013 | 6542 | 0.040 |
Why?
|
Parasympathetic Nervous System | 1 | 1999 | 141 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2007 | 3921 | 0.040 |
Why?
|
Receptors, Interleukin-3 | 1 | 1997 | 30 | 0.040 |
Why?
|
Lung Compliance | 3 | 1998 | 195 | 0.040 |
Why?
|
Immunoassay | 1 | 2001 | 752 | 0.040 |
Why?
|
Chemokine CXCL1 | 2 | 2011 | 101 | 0.040 |
Why?
|
Growth Substances | 1 | 2000 | 784 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 1999 | 17445 | 0.040 |
Why?
|
Vital Capacity | 3 | 2010 | 925 | 0.040 |
Why?
|
Acute Disease | 1 | 2008 | 7147 | 0.040 |
Why?
|
Pulmonary Alveolar Proteinosis | 1 | 1997 | 42 | 0.040 |
Why?
|
Female | 21 | 2012 | 380200 | 0.040 |
Why?
|
Infection Control | 1 | 2004 | 965 | 0.040 |
Why?
|
Forced Expiratory Volume | 3 | 2012 | 1745 | 0.040 |
Why?
|
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1997 | 110 | 0.040 |
Why?
|
Adult | 8 | 2013 | 214056 | 0.040 |
Why?
|
Eosinophils | 1 | 2002 | 955 | 0.040 |
Why?
|
Organ Specificity | 1 | 2002 | 2008 | 0.040 |
Why?
|
Neutropenia | 1 | 2002 | 895 | 0.040 |
Why?
|
Culture Techniques | 1 | 1997 | 554 | 0.040 |
Why?
|
Molecular Sequence Data | 2 | 2007 | 18111 | 0.030 |
Why?
|
Receptors, Interleukin | 1 | 1997 | 245 | 0.030 |
Why?
|
Prevalence | 1 | 2013 | 15221 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2001 | 1200 | 0.030 |
Why?
|
Virulence | 2 | 1992 | 1333 | 0.030 |
Why?
|
Eosinophilia | 2 | 1998 | 541 | 0.030 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2003 | 1677 | 0.030 |
Why?
|
Receptors, Cell Surface | 1 | 2005 | 2866 | 0.030 |
Why?
|
Cells, Cultured | 6 | 2012 | 19233 | 0.030 |
Why?
|
Risk Factors | 4 | 2008 | 72295 | 0.030 |
Why?
|
Blood | 1 | 1997 | 598 | 0.030 |
Why?
|
Ergolines | 1 | 1994 | 61 | 0.030 |
Why?
|
Host-Pathogen Interactions | 2 | 2013 | 1480 | 0.030 |
Why?
|
Nitric Oxide Synthase | 1 | 1997 | 915 | 0.030 |
Why?
|
Antigens, CD | 2 | 2001 | 4026 | 0.030 |
Why?
|
gamma-Globulins | 1 | 1993 | 124 | 0.030 |
Why?
|
Lung Diseases, Interstitial | 2 | 2005 | 808 | 0.030 |
Why?
|
Adolescent | 5 | 2012 | 85784 | 0.030 |
Why?
|
Herpes Simplex | 1 | 1997 | 470 | 0.030 |
Why?
|
Atropine | 1 | 1994 | 244 | 0.030 |
Why?
|
Child | 5 | 2013 | 77708 | 0.030 |
Why?
|
Serotonin Antagonists | 1 | 1994 | 144 | 0.030 |
Why?
|
Receptors, IgG | 1 | 1997 | 582 | 0.030 |
Why?
|
Gene Expression Regulation | 2 | 2009 | 12073 | 0.030 |
Why?
|
Simplexvirus | 1 | 1997 | 803 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2010 | 7281 | 0.030 |
Why?
|
Plethysmography | 2 | 1995 | 180 | 0.030 |
Why?
|
Serotonin Receptor Agonists | 1 | 1994 | 152 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2006 | 11366 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2011 | 3873 | 0.030 |
Why?
|
Trachea | 2 | 1989 | 1076 | 0.030 |
Why?
|
Phenazines | 1 | 2012 | 58 | 0.030 |
Why?
|
Mice, Inbred CBA | 3 | 1998 | 448 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 2 | 1995 | 8300 | 0.030 |
Why?
|
Age Factors | 4 | 2010 | 18373 | 0.030 |
Why?
|
Signal Transduction | 2 | 2010 | 23406 | 0.030 |
Why?
|
Skin Physiological Phenomena | 1 | 1993 | 180 | 0.030 |
Why?
|
T-Lymphocytes | 3 | 2000 | 10183 | 0.030 |
Why?
|
Murine pneumonia virus | 1 | 2011 | 4 | 0.030 |
Why?
|
Bacterial Load | 1 | 2012 | 153 | 0.030 |
Why?
|
Chimera | 1 | 1993 | 485 | 0.030 |
Why?
|
Heparan Sulfate Proteoglycans | 1 | 2012 | 118 | 0.030 |
Why?
|
Immune Tolerance | 1 | 2000 | 2259 | 0.030 |
Why?
|
Chemokine CCL3 | 1 | 2011 | 84 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2010 | 7182 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 1998 | 1837 | 0.030 |
Why?
|
Recombinant Proteins | 2 | 2010 | 6621 | 0.020 |
Why?
|
Histamine | 2 | 1994 | 507 | 0.020 |
Why?
|
Dermatitis, Atopic | 1 | 1998 | 654 | 0.020 |
Why?
|
Phenotype | 2 | 2006 | 16367 | 0.020 |
Why?
|
Respiratory Syncytial Viruses | 1 | 2011 | 165 | 0.020 |
Why?
|
Listeria | 1 | 1990 | 27 | 0.020 |
Why?
|
Sputum | 1 | 2012 | 476 | 0.020 |
Why?
|
Calcimycin | 1 | 1990 | 222 | 0.020 |
Why?
|
Phosphoproteins | 1 | 1999 | 2441 | 0.020 |
Why?
|
Thromboxane B2 | 1 | 1990 | 152 | 0.020 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2012 | 339 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 1998 | 4777 | 0.020 |
Why?
|
Blood Pressure | 2 | 2008 | 8551 | 0.020 |
Why?
|
Macrophage Activation | 1 | 1992 | 560 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 2000 | 3037 | 0.020 |
Why?
|
Reference Values | 2 | 2005 | 4982 | 0.020 |
Why?
|
Arachidonic Acids | 1 | 1990 | 299 | 0.020 |
Why?
|
Oropharynx | 1 | 2010 | 127 | 0.020 |
Why?
|
Up-Regulation | 2 | 2012 | 4222 | 0.020 |
Why?
|
Metagenome | 1 | 2012 | 418 | 0.020 |
Why?
|
Surface Plasmon Resonance | 1 | 2010 | 274 | 0.020 |
Why?
|
Clodronic Acid | 1 | 2008 | 60 | 0.020 |
Why?
|
Methacholine Compounds | 1 | 1988 | 35 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2005 | 16692 | 0.020 |
Why?
|
Biological Factors | 1 | 1990 | 164 | 0.020 |
Why?
|
Selection, Genetic | 1 | 2013 | 914 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2013 | 13104 | 0.020 |
Why?
|
Middle Aged | 5 | 2012 | 213388 | 0.020 |
Why?
|
Cell Adhesion | 2 | 1998 | 3144 | 0.020 |
Why?
|
Arachidonic Acid | 1 | 1990 | 434 | 0.020 |
Why?
|
Death | 1 | 1993 | 678 | 0.020 |
Why?
|
SRS-A | 1 | 1988 | 156 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2005 | 7882 | 0.020 |
Why?
|
Platelet Activating Factor | 1 | 1988 | 149 | 0.020 |
Why?
|
Lung Diseases | 1 | 1998 | 1887 | 0.020 |
Why?
|
Histocompatibility Antigens Class II | 1 | 1992 | 1475 | 0.020 |
Why?
|
Cricetulus | 1 | 2010 | 818 | 0.020 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2012 | 571 | 0.020 |
Why?
|
Radiation Chimera | 2 | 1998 | 223 | 0.020 |
Why?
|
Indomethacin | 1 | 1988 | 332 | 0.020 |
Why?
|
Antibodies, Blocking | 1 | 2008 | 253 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2006 | 15520 | 0.020 |
Why?
|
United States | 2 | 2013 | 69869 | 0.020 |
Why?
|
Prostaglandins | 1 | 1988 | 405 | 0.020 |
Why?
|
Hypotension | 1 | 1993 | 884 | 0.020 |
Why?
|
Dinoprostone | 1 | 1990 | 601 | 0.020 |
Why?
|
CHO Cells | 1 | 2010 | 1409 | 0.020 |
Why?
|
Substance P | 1 | 1988 | 335 | 0.020 |
Why?
|
Mathematics | 1 | 1988 | 728 | 0.020 |
Why?
|
Positive-Pressure Respiration | 1 | 2011 | 633 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 1995 | 4740 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2013 | 1312 | 0.020 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2010 | 437 | 0.020 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2010 | 675 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 1990 | 20130 | 0.020 |
Why?
|
Propranolol | 1 | 1988 | 502 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2887 | 0.020 |
Why?
|
Injections, Subcutaneous | 1 | 1988 | 667 | 0.020 |
Why?
|
Cricetinae | 1 | 2010 | 2475 | 0.020 |
Why?
|
Heart Rate | 2 | 1997 | 4091 | 0.020 |
Why?
|
Pilocarpine | 1 | 2005 | 63 | 0.020 |
Why?
|
Lymphocyte Depletion | 2 | 1998 | 608 | 0.020 |
Why?
|
Ecosystem | 1 | 2010 | 474 | 0.020 |
Why?
|
Cell Separation | 1 | 2011 | 1751 | 0.020 |
Why?
|
Norepinephrine | 1 | 1988 | 909 | 0.020 |
Why?
|
Muscarinic Agonists | 1 | 2005 | 87 | 0.020 |
Why?
|
Liposomes | 1 | 2008 | 759 | 0.020 |
Why?
|
Gene Expression | 2 | 2011 | 7798 | 0.020 |
Why?
|
Bronchi | 1 | 1989 | 840 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 1997 | 10943 | 0.020 |
Why?
|
Protein Binding | 2 | 2010 | 9384 | 0.020 |
Why?
|
False Negative Reactions | 1 | 2005 | 588 | 0.020 |
Why?
|
Aged | 3 | 2006 | 163284 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2001 | 21747 | 0.010 |
Why?
|
Immunity, Cellular | 1 | 1990 | 1607 | 0.010 |
Why?
|
Extracellular Space | 1 | 2005 | 595 | 0.010 |
Why?
|
Decision Trees | 1 | 2005 | 506 | 0.010 |
Why?
|
Child, Preschool | 3 | 2010 | 41005 | 0.010 |
Why?
|
Capillary Permeability | 2 | 1998 | 798 | 0.010 |
Why?
|
False Positive Reactions | 1 | 2005 | 980 | 0.010 |
Why?
|
Heparin | 1 | 2010 | 1637 | 0.010 |
Why?
|
Receptors, CCR3 | 1 | 2002 | 62 | 0.010 |
Why?
|
Syndrome | 2 | 2000 | 3252 | 0.010 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2005 | 638 | 0.010 |
Why?
|
Time Factors | 2 | 2001 | 40077 | 0.010 |
Why?
|
Kinetics | 1 | 2010 | 6476 | 0.010 |
Why?
|
Bacteremia | 1 | 2008 | 963 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 2003 | 898 | 0.010 |
Why?
|
Albumins | 1 | 2003 | 568 | 0.010 |
Why?
|
Community-Acquired Infections | 1 | 2004 | 465 | 0.010 |
Why?
|
Early Diagnosis | 1 | 2005 | 1184 | 0.010 |
Why?
|
Kidney | 2 | 1995 | 7184 | 0.010 |
Why?
|
Passive Cutaneous Anaphylaxis | 1 | 1999 | 35 | 0.010 |
Why?
|
Genotype | 2 | 2010 | 12952 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2003 | 2050 | 0.010 |
Why?
|
Bronchitis | 1 | 1980 | 200 | 0.010 |
Why?
|
Base Sequence | 2 | 2003 | 12797 | 0.010 |
Why?
|
Canada | 1 | 2004 | 2065 | 0.010 |
Why?
|
Pneumonia, Viral | 1 | 1997 | 3242 | 0.010 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 2000 | 279 | 0.010 |
Why?
|
Methylprednisolone | 1 | 1980 | 387 | 0.010 |
Why?
|
Staphylococcal Infections | 1 | 1988 | 1400 | 0.010 |
Why?
|
Mice, Inbred BALB C | 2 | 1998 | 6387 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 1989 | 5524 | 0.010 |
Why?
|
Isoantigens | 1 | 2000 | 567 | 0.010 |
Why?
|
Receptors, Interleukin-5 | 1 | 1997 | 19 | 0.010 |
Why?
|
Staphylococcus aureus | 1 | 2006 | 1453 | 0.010 |
Why?
|
Recurrence | 1 | 1990 | 8340 | 0.010 |
Why?
|
omega-N-Methylarginine | 1 | 1997 | 111 | 0.010 |
Why?
|
CD4-CD8 Ratio | 1 | 1997 | 112 | 0.010 |
Why?
|
Bronchoconstrictor Agents | 1 | 1997 | 77 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2003 | 4320 | 0.010 |
Why?
|
Histocompatibility | 1 | 1998 | 330 | 0.010 |
Why?
|
Prospective Studies | 1 | 2001 | 53291 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 1994 | 9647 | 0.010 |
Why?
|
Enzyme Induction | 1 | 1997 | 475 | 0.010 |
Why?
|
Young Adult | 2 | 2013 | 56434 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2005 | 4185 | 0.010 |
Why?
|
Thymectomy | 1 | 1997 | 191 | 0.010 |
Why?
|
Immunotherapy | 1 | 2012 | 4445 | 0.010 |
Why?
|
Parasympathomimetics | 1 | 1995 | 26 | 0.010 |
Why?
|
Genes, Immunoglobulin | 1 | 1997 | 291 | 0.010 |
Why?
|
Research | 1 | 2004 | 1999 | 0.010 |
Why?
|
Ligands | 1 | 2003 | 3282 | 0.010 |
Why?
|
Airway Resistance | 1 | 1997 | 404 | 0.010 |
Why?
|
Administration, Cutaneous | 1 | 1998 | 711 | 0.010 |
Why?
|
Antibody Specificity | 1 | 1998 | 1095 | 0.010 |
Why?
|
Mice, Inbred A | 1 | 1995 | 248 | 0.010 |
Why?
|
Adrenal Cortex Hormones | 1 | 2004 | 1856 | 0.010 |
Why?
|
Linear Models | 1 | 2005 | 5952 | 0.010 |
Why?
|
Lod Score | 1 | 1995 | 614 | 0.010 |
Why?
|
Transfection | 1 | 2003 | 5895 | 0.010 |
Why?
|
Drug Resistance | 1 | 2000 | 1608 | 0.010 |
Why?
|
Survival Rate | 1 | 2008 | 12788 | 0.010 |
Why?
|
Crosses, Genetic | 1 | 1995 | 791 | 0.010 |
Why?
|
DNA Primers | 1 | 1998 | 2891 | 0.010 |
Why?
|
Patient Selection | 1 | 2005 | 4216 | 0.010 |
Why?
|
Down-Regulation | 1 | 2000 | 3001 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2005 | 9735 | 0.010 |
Why?
|
Liver | 1 | 2008 | 7475 | 0.010 |
Why?
|
Massachusetts | 1 | 2005 | 8662 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2005 | 3529 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2004 | 2987 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 1999 | 2513 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2012 | 25041 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2003 | 13814 | 0.010 |
Why?
|
Homeostasis | 1 | 2002 | 3339 | 0.010 |
Why?
|
Binding Sites | 1 | 1999 | 6111 | 0.010 |
Why?
|
Genetic Linkage | 1 | 1995 | 2421 | 0.010 |
Why?
|
Mammals | 1 | 1995 | 1143 | 0.010 |
Why?
|
Sequence Deletion | 1 | 1994 | 1526 | 0.010 |
Why?
|
Mice, SCID | 1 | 1994 | 2717 | 0.010 |
Why?
|
Cell Line | 1 | 2003 | 16000 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 1999 | 2918 | 0.010 |
Why?
|
Postoperative Complications | 1 | 1990 | 15295 | 0.000 |
Why?
|
Heart Arrest | 1 | 1997 | 1470 | 0.000 |
Why?
|
Enzyme Inhibitors | 1 | 1997 | 3799 | 0.000 |
Why?
|
Polymerase Chain Reaction | 1 | 1995 | 6171 | 0.000 |
Why?
|
Mortality | 1 | 1997 | 2864 | 0.000 |
Why?
|
Infant, Newborn | 1 | 2005 | 25628 | 0.000 |
Why?
|
Algorithms | 1 | 2005 | 13882 | 0.000 |
Why?
|
Hemorrhage | 1 | 1996 | 3461 | 0.000 |
Why?
|
Hemodynamics | 1 | 1994 | 4196 | 0.000 |
Why?
|
Graft vs Host Disease | 1 | 1996 | 2958 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 2005 | 39052 | 0.000 |
Why?
|
Cell Differentiation | 1 | 1999 | 11486 | 0.000 |
Why?
|
DNA | 1 | 1995 | 7294 | 0.000 |
Why?
|
Bronchospirometry | 1 | 1980 | 10 | 0.000 |
Why?
|
Models, Biological | 1 | 1997 | 9584 | 0.000 |
Why?
|
Theophylline | 1 | 1980 | 132 | 0.000 |
Why?
|
Proteins | 1 | 1994 | 6100 | 0.000 |
Why?
|
Carbon Dioxide | 1 | 1980 | 1150 | 0.000 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1980 | 2556 | 0.000 |
Why?
|
Double-Blind Method | 1 | 1980 | 12025 | 0.000 |
Why?
|
Chronic Disease | 1 | 1980 | 9145 | 0.000 |
Why?
|
Clinical Trials as Topic | 1 | 1980 | 7914 | 0.000 |
Why?
|